Evidence map›Paper›PMID 27128969›Full record

ArticlePLoS pathogens2016

The SH3BGR/STAT3 Pathway Regulates Cell Migration and Angiogenesis Induced by a Gammaherpesvirus MicroRNA.

Wan Li, Qin Yan, Xiangya Ding, Chenyou Shen, Minmin Hu, Ying Zhu, Di Qin, Hongmei Lu, Brian J Krueger, Rolf Renne and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Biphasic Effect of Pirfenidone on Angiogenesis.Frontiers in pharmacology · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Wan LiState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, People's Republic of China.
Qin YanDepartment of Microbiology, Nanjing Medical University, Nanjing, People's Republic of China.
Xiangya DingDepartment of Microbiology, Nanjing Medical University, Nanjing, People's Republic of China.
Chenyou ShenDepartment of Microbiology, Nanjing Medical University, Nanjing, People's Republic of China.
Minmin HuDepartment of Microbiology, Nanjing Medical University, Nanjing, People's Republic of China.
Ying ZhuDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Di QinDepartment of Microbiology, Nanjing Medical University, Nanjing, People's Republic of China.
Hongmei LuDepartment of Obstetrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Brian J KruegerDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
Rolf RenneDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
Shou-Jiang GaoDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Chun LuState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, People's Republic of China.
Nanjing Medical University · CNUniversity of Florida · USUniversity of Southern California · US

Funding

Roles of the K3 and K5 in KSHV Persistence and PathogenesisP01CA180779 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2013 to 2017
$7.3M
Regulation of KSHV replication by N6-methyladenosine (m6A) - Diversity SupplementR01CA124332 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GAO, SHOU-JIANG · 2007 to 2025
$5.0M
Mechanism of KSHV-induced angiogenesisR01CA132637 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GAO, SHOU-JIANG · 2008 to 2020
$3.6M
Studying the role of KSHV-encoded miRNAsR01CA119917 · NCI · UNIVERSITY OF FLORIDA · PI RENNE, ROLF F · 2008 to 2017
$3.2M
KSHVmediated regulation of proline metabolismR01DE028521 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2019 to 2023
$2.4M
HISTONE MODIFIERS IN ORAL KSHV INFECTION AND MALIGNANCIESR01DE025465 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GAO, SHOU-JIANG · 2015 to 2019
$2.0M
Targeting KSHV malignancies and persistent infectionR01CA197153 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GAO, SHOU-JIANG · 2015 to 2019
$1.9M
KSHV microRNAs in cellular transformation and tumorigenesisR01CA177377 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GAO, SHOU-JIANG · 2013 to 2015
$596k
NCI NIH HHS P01 CA180779NCI NIH HHS R01 CA119917NCI NIH HHS R01 CA124332NCI NIH HHS R01 CA132637NCI NIH HHS R01 CA177377NCI NIH HHS R01 CA197153NIDCR NIH HHS R01 DE025465NIDCR NIH HHS R01 DE028521
6 · The paper itself

Abstract

Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is a gammaherpesvirus etiologically associated with KS, a highly disseminated angiogenic tumor of hyperproliferative spindle endothelial cells. KSHV encodes 25 mature microRNAs but their roles in KSHV-induced tumor dissemination and angiogenesis remain unknown. Here, we investigated KSHV-encoded miR-K12-6-3p (miR-K6-3p) promotion of endothelial cell migration and angiogenesis, which are the underlying mechanisms of tumor dissemination and angiogenesis. We found that ectopic expression of miR-K6-3p promoted endothelial cell migration and angiogenesis. Mass spectrometry, bioinformatics and luciferase reporter analyses revealed that miR-K6-3p directly targeted sequence in the 3' untranslated region (UTR) of SH3 domain binding glutamate-rich protein (SH3BGR). Overexpression of SH3BGR reversed miR-K6-3p induction of cell migration and angiogenesis. Mechanistically, miR-K6-3p downregulated SH3BGR, hence relieved STAT3 from SH3BGR direct binding and inhibition, which was required for miR-K6-3p maximum activation of STAT3 and induction of cell migration and angiogenesis. Finally, deletion of miR-K6 from the KSHV genome abrogated its effect on the SH3BGR/STAT3 pathway, and KSHV-induced migration and angiogenesis. Our results illustrated that, by inhibiting SH3BGR, miR-K6-3p enhances cell migration and angiogenesis by activating the STAT3 pathway, and thus contributes to the dissemination and angiogenesis of KSHV-induced malignancies.

Indexed as

MicroRNAsRNA, ViralAnimalsBlotting, WesternCell MovementHerpesvirus 8, HumanHumansHuman Umbilical Vein Endothelial CellsImmunohistochemistryImmunoprecipitationMiceMice, NudeMicroscopy, ConfocalMuscle ProteinsNeovascularization, PathologicPolymerase Chain ReactionMicroRNAsMuscle ProteinsRNA, ViralSH3BGR protein, humanSTAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID27128969
PMCPMC4851422
OpenAlexW2343051666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.